# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-21-000030
Filing Date
2021-08-12
Accepted
2021-08-12 16:17:17
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sls-20210630.htm iXBRL | 10-Q | 1104220
2 | EX-10.1 | sls-20160630ex101.htm | EX-10.1 | 61232
3 | EX-31.1 | sls-20210630ex311.htm | EX-31.1 | 8301
4 | EX-31.2 | sls-20210630ex312.htm | EX-31.2 | 8305
5 | EX-32.1 | sls-20210630ex321.htm | EX-32.1 | 6713
11 |  | sls-20210630_g1.jpg | GRAPHIC | 30719
| Complete submission text file | 0001390478-21-000030.txt |  | 5513182

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sls-20210630.xsd | EX-101.SCH | 44110
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | sls-20210630_cal.xml | EX-101.CAL | 53259
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sls-20210630_def.xml | EX-101.DEF | 164207
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sls-20210630_lab.xml | EX-101.LAB | 491914
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sls-20210630_pre.xml | EX-101.PRE | 323228
12 | EXTRACTED XBRL INSTANCE DOCUMENT | sls-20210630_htm.xml | XML | 869234

Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 211167810
SIC: 2834 Pharmaceutical Preparations